BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22760199)

  • 1. Sensitization of glioma cells by X-linked inhibitor of apoptosis protein knockdown.
    Lopez PL; Filippi-Chiela EC; Silva AO; Cordero EA; Garcia-Santos D; Pelegrini AL; Reder GM; Barbieri NL; Lenz G
    Oncology; 2012; 83(2):75-82. PubMed ID: 22760199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of XIAP by AEG35156 in paediatric tumour cells induces apoptosis and sensitises cells to cytotoxic agents.
    Holt SV; Brookes KE; Dive C; Makin GW
    Oncol Rep; 2011 Apr; 25(4):1177-81. PubMed ID: 21286665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. XIAP gene downregulation by small interfering RNA inhibits proliferation, induces apoptosis, and reverses the cisplatin resistance of ovarian carcinoma.
    Ma JJ; Chen BL; Xin XY
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):222-6. PubMed ID: 19758744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
    Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
    Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topotecan triggers apoptosis in p53-deficient cells by forcing degradation of XIAP and survivin thereby activating caspase-3-mediated Bid cleavage.
    Tomicic MT; Christmann M; Kaina B
    J Pharmacol Exp Ther; 2010 Jan; 332(1):316-25. PubMed ID: 19812371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
    Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
    Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.
    Asselin E; Mills GB; Tsang BK
    Cancer Res; 2001 Mar; 61(5):1862-8. PubMed ID: 11280739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Akt and XIAP regulate the sensitivity of human uterine cancer cells to cisplatin, doxorubicin and taxol.
    Gagnon V; Van Themsche C; Turner S; Leblanc V; Asselin E
    Apoptosis; 2008 Feb; 13(2):259-71. PubMed ID: 18071906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Hörnle M; Peters N; Thayaparasingham B; Vörsmann H; Kashkar H; Kulms D
    Oncogene; 2011 Feb; 30(5):575-87. PubMed ID: 20856198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific downregulation of bcl-2 and xIAP by RNAi enhances the effects of chemotherapeutic agents in MCF-7 human breast cancer cells.
    Lima RT; Martins LM; Guimarães JE; Sambade C; Vasconcelos MH
    Cancer Gene Ther; 2004 May; 11(5):309-16. PubMed ID: 15031723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral expression of XIAP antisense RNA induces apoptosis in glioma cells and suppresses the growth of xenografts in nude mice.
    Naumann U; Bähr O; Wolburg H; Altenberend S; Wick W; Liston P; Ashkenazi A; Weller M
    Gene Ther; 2007 Jan; 14(2):147-61. PubMed ID: 16957768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterotrimeric stimulatory GTP-binding proteins inhibit cisplatin-induced apoptosis by increasing X-linked inhibitor of apoptosis protein expression in cervical cancer cells.
    Cho EA; Oh JM; Kim SY; Kim Y; Juhnn YS
    Cancer Sci; 2011 Apr; 102(4):837-44. PubMed ID: 21255191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induced by adenovirus-mediated p53 gene transfer in human glioma correlates with site-specific phosphorylation.
    Shono T; Tofilon PJ; Schaefer TS; Parikh D; Liu TJ; Lang FF
    Cancer Res; 2002 Feb; 62(4):1069-76. PubMed ID: 11861384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo.
    Hu Y; Cherton-Horvat G; Dragowska V; Baird S; Korneluk RG; Durkin JP; Mayer LD; LaCasse EC
    Clin Cancer Res; 2003 Jul; 9(7):2826-36. PubMed ID: 12855663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of NF-kappaB activation in a H4IIE transfectant insensitive to doxorubicin-induced apoptosis.
    Chovolou Y; Wätjen W; Kampkötter A; Kahl R
    Toxicology; 2007 Mar; 232(1-2):89-98. PubMed ID: 17223244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine a induces growth arrest or programmed cell death of human glioma cells.
    Zupanska A; Dziembowska M; Ellert-Miklaszewska A; Gaweda-Walerych K; Kaminska B
    Neurochem Int; 2005 Nov; 47(6):430-41. PubMed ID: 16087277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sensitivity of malignant glioma cells to methylating and chloroethylating anticancer drugs: p53 determines the switch by regulating xpc, ddb2, and DNA double-strand breaks.
    Batista LF; Roos WP; Christmann M; Menck CF; Kaina B
    Cancer Res; 2007 Dec; 67(24):11886-95. PubMed ID: 18089819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents.
    Arizono Y; Yoshikawa H; Naganuma H; Hamada Y; Nakajima Y; Tasaka K
    Br J Cancer; 2003 Jan; 88(2):298-306. PubMed ID: 12610517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. XIAP-mediated protection of H460 lung cancer cells against cisplatin.
    Cheng YJ; Jiang HS; Hsu SL; Lin LC; Wu CL; Ghanta VK; Hsueh CM
    Eur J Pharmacol; 2010 Feb; 627(1-3):75-84. PubMed ID: 19903469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.